Loxo Oncology Backtesting

LOXO -- USA Stock  

USD 157.30  1.55  1.00%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Loxo Oncology and determine expected loss or profit from investing in Loxo Oncology over given investment horizon. Please see also Loxo Oncology Hype Analysis, Loxo Oncology Correlation, Loxo Oncology Valuation, Loxo Oncology Volatility as well as analyze Loxo Oncology Alpha and Beta and Loxo Oncology Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

Loxo Oncology 'What if' Analysis

August 21, 2018
0.00
No Change 0.00  0.0%
In 31 days
September 20, 2018
0.00
If you would invest  0.00  in Loxo Oncology on August 21, 2018 and sell it all today you would earn a total of 0.00 from holding Loxo Oncology or generate 0.0% return on investment in Loxo Oncology over 30 days. Loxo Oncology is related to or competes with China Cord, NantKwest, DelMar Pharmaceuticals, Denali Therapeutics, Dova Pharmaceuticals, Dicerna Pharmaceuticals, and Dynavax Technologies. Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined can...

Loxo Oncology Upside/Downside Indicators

Information Ratio0.08
Maximum Drawdown8.43
Value At Risk4.12
Potential Upside2.69
  

Loxo Oncology Market Premium Indicators

Risk Adjusted Performance0.00636
Jensen Alpha0.08
Total Risk Alpha0.61
Treynor Ratio0.9384

Loxo Oncology Backtested Returns

Macroaxis considers Loxo Oncology to be not too risky. Loxo Oncology has Sharpe Ratio of -0.0374 which conveys that Loxo Oncology had -0.0374% of return per unit of risk over the last 1 month. Macroaxis philosophy towards estimating risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Loxo Oncology exposes twenty-eight different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Loxo Oncology Mean Deviation of 1.64 and Risk Adjusted Performance of 0.00636 to check out risk estimate we provide. Macroaxis gives Loxo Oncology performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of -0.0978 which conveys that as returns on market increase, returns on owning Loxo Oncology are expected to decrease at a much smaller rate. During bear market, Loxo Oncology is likely to outperform the market.. Even though it is essential to pay attention to Loxo Oncology price patterns, it is always good to be careful when utilizing equity historical price patterns. Macroaxis philosophy towards estimating future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Loxo Oncology exposes twenty-eight different technical indicators which can help you to evaluate its performance. Loxo Oncology has expected return of -0.082%. Please be advised to verify Loxo Oncology Treynor Ratio, Expected Short fall as well as the relationship between Expected Short fall and Day Median Price to decide if Loxo Oncology past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.46) 

Modest reverse predictability

Loxo Oncology has modest reverse predictability. Overlapping area represents the amount of predictability between Loxo Oncology time series from August 21, 2018 to September 5, 2018 and September 5, 2018 to September 20, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Loxo Oncology price movement. The serial correlation of -0.46 indicates that about 46.0% of current Loxo Oncology price fluctuation can be explain by its past prices. Given that Loxo Oncology has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Loxo Oncology for similar time interval.
Correlation Coefficient-0.46
Spearman Rank Test-0.66
Residual Average0.0
Price Variance22.78

Loxo Oncology lagged returns against current returns

 Current and Lagged Values 
      Timeline 

Loxo Oncology regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

Loxo Oncology Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - LOXO

Loxo Oncology Investor Sentiment

Most of Macroaxis users are now bullish on Loxo Oncology. What is your trading attitude regarding investing in Loxo Oncology? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Loxo Oncology Hype Analysis, Loxo Oncology Correlation, Loxo Oncology Valuation, Loxo Oncology Volatility as well as analyze Loxo Oncology Alpha and Beta and Loxo Oncology Performance. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Search macroaxis.com